C12Y 101/01034
Hydroxymethylglutaryl-coa reductase
Official title: Hydroxymethylglutaryl-CoA reductase (NADPH) (1.1.1.34)
C12Y101/01034 (Hydroxymethylglutaryl-coa reductase) appears on 62 US grants and 104 published applications in this corpus.
Search patents in C12Y- Granted patents
- 62
- Published applications
- 104
- Assignees
- 58
- Inventors
- 221
- Latest grant
- 19 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 4 |
| 2004 | 2 | 3 |
| 2005 | 0 | 2 |
| 2006 | 1 | 2 |
| 2007 | 1 | 5 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 4 | 2 |
| 2011 | 3 | 3 |
| 2012 | 2 | 3 |
| 2013 | 2 | 3 |
| 2014 | 4 | 2 |
| 2015 | 2 | 5 |
| 2016 | 1 | 10 |
| 2017 | 6 | 5 |
| 2018 | 5 | 12 |
| 2019 | 8 | 9 |
| 2020 | 4 | 3 |
| 2021 | 5 | 7 |
| 2022 | 3 | 4 |
| 2023 | 1 | 4 |
| 2024 | 3 | 4 |
| 2025 | 2 | 5 |
| 2026 | 0 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Metabolic engineering19 Aug 2025US 12,391,963 B2Plant Bioscience Limited
- Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids12 Aug 2025US 12,385,072 B2Khona Scientific Holdings, Inc.
- Method for increasing the yield of oxidosqualene, triterpenes and/or triterpenoids and host cell therefore5 Nov 2024US 12,134,787 B2Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e. V.
- Increased biosynthesis of benzylisoquinoline alkaloids and benzylisoquinoline alkaloid precursors in a recombinant host cell23 Apr 2024US 11,965,181 B2River Stone Biotech, LLC
- Production of cannabinoids in yeast26 Mar 2024US 11,939,613 B2BioMediCan, Inc.
- Gene combination and method for biosynthesis of crocins27 Aug 2026US 2026/0250702 A1Shanghai Academy of Agricultural Sciences
- Variant isph and method for synthesizing compound having, as structural unit, isoprene obtained by using said variant enzyme13 Aug 2026US 2026/0234678 A1National University Corporation Chiba University
- Novel rna therapeutics and uses thereof23 Jul 2026US 2026/0209772 A1Eli Lilly and Company
- Production of cannabinoids and engineered cells therefor23 Jul 2026US 2026/0209780 A1Cellibre, Inc.
- Bioproduction of isoprenoids12 Feb 2026US 2026/0043051 A1Inscripta, Inc.
Most cited
By later US patents
- Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use239US 5,176,996 ABaylor College of Medicine · 1993
- Production of farnesol and geranylgeraniol87US 6,689,593 B2Arkion Life Sciences, LLC · 2004
- Method of producing geranylgeraniol76US 6,531,303 B1Arkion Life Sciences, LLC · 2003
- Production of acetyl-coenzyme a derived isoprenoids31US 8,415,136 B1Amyris, Inc. · 2013
- Isoprenoid production29US 6,989,257 B2Dsm IP Assets B.V. · 2006